Follow‐up after systemic adverse reactions of immunotherapy

Elias Toubi(Bnai Zion Medical Center), TD Golan(Bnai Zion Medical Center), A Blant(Bnai Zion Medical Center), Aharon Kessel(Technion – Israel Institute of Technology)
Allergy
June 1, 1999
10.1034/j.1398-9995.1999.t01-1-00094.x
Cited by 18

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|428
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients
|Allergy|2004|301